Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Sells $19,376,470.35 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder J.H. Whitney Equity Partners V sold 2,419,035 shares of Aveanna Healthcare stock in a transaction that occurred on Tuesday, June 30th. The shares were sold at an average price of $8.01, for a total transaction of $19,376,470.35. Following the sale, the insider owned 10,112,123 shares of the company’s stock, valued at approximately $80,998,105.23. The trade was a 19.30% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

J.H. Whitney Equity Partners V also recently made the following trade(s):

• On Wednesday, June 24th, J.H. Whitney Equity Partners V sold 919,389 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.00, for a total value of $7,355,112.00.
• On Wednesday, June 3rd, J.H. Whitney Equity Partners V sold 5,842,240 shares of Aveanna Healthcare stock. The shares were sold at an average price of $6.24, for a total transaction of $36,455,577.60.

Aveanna Healthcare Stock Performance

Shares of NASDAQ AVAH opened at $9.10 on Friday. The company has a market capitalization of $1.98 billion, a PE ratio of 7.71, a price-to-earnings-growth ratio of 0.94 and a beta of 1.89. The company has a debt-to-equity ratio of 5.35, a quick ratio of 1.47 and a current ratio of 1.47. The company’s fifty day moving average price is $7.36 and its 200 day moving average price is $7.57. Aveanna Healthcare Holdings Inc. has a 1 year low of $3.73 and a 1 year high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last issued its quarterly earnings data on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of $0.13 by $0.05. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The business had revenue of $647.91 million during the quarter, compared to the consensus estimate of $613.22 million. The company’s revenue for the quarter was up 15.9% on a year-over-year basis. On average, research analysts predict that Aveanna Healthcare Holdings Inc. will post 0.65 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms have recently commented on AVAH. Royal Bank Of Canada upgraded Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price objective for the company in a research report on Wednesday, June 3rd. Weiss Ratings lowered shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, April 6th. Truist Financial upped their price objective on shares of Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “hold” rating in a research report on Wednesday, May 20th. Raymond James Financial raised shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price objective on the stock in a report on Friday, March 20th. Finally, BMO Capital Markets cut their target price on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating for the company in a research note on Friday, March 20th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, Aveanna Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $10.50.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in AVAH. Caitong International Asset Management Co. Ltd lifted its holdings in Aveanna Healthcare by 252.4% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after purchasing an additional 2,400 shares in the last quarter. Summit Securities Group LLC acquired a new stake in shares of Aveanna Healthcare in the first quarter valued at about $53,000. Quantbot Technologies LP acquired a new stake in shares of Aveanna Healthcare in the second quarter valued at about $43,000. EverSource Wealth Advisors LLC lifted its stake in shares of Aveanna Healthcare by 88,100.0% in the third quarter. EverSource Wealth Advisors LLC now owns 11,466 shares of the company’s stock worth $102,000 after buying an additional 11,453 shares in the last quarter. Finally, Entropy Technologies LP purchased a new position in shares of Aveanna Healthcare in the third quarter worth about $107,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.